Price: $30.00 /per person
Location image of event venue


Clinical, biotech, genomic, and diagnostic innovations are converging with health tech to anticipate, target, manage and cure a wide range of diseases. At this event, we will explore the state of the art in this field and the companies at the forefront.


6 PM - Meet Tweet & Greet - healthy snacks and networking time

6:15 - Opening Remarks and Keynote

6:30 - Three Innovators in the space present their innovations to a panel of experts who ask questions

7:15 - Networking Break

7:45 - Panel Discussion

8:15 - Open Bar and Networking Time Sponsored by Chardan

9:30 - After Event off site

Dues paying Members Only: Free!

Thank you for your support for this group and our mission. If you have an idea, please be welcome to use the "Suggest a meetup" option above. Many of our best ideas are crowd sourced and we appreciate your input.


If you are a dues paying member, please use your free code on or just register for a penny here.

You can pay at the door but we may have to turn you away for fire code issues and it will cost you $40 so please register online to reserve a spot.


Mette Dyhrberg ( - Founder & CEO mymee, Patient Activist - Mette Dyhrberg is founder of Mymee and digital health innovator. An economist turned diagnostician, who hacked her own health after years with chronic health issues. Mymee is a digital therapeutics program that helps detect triggers to reverse autoimmune disease symptoms. Her coaching methods have already helped restore quality of life of people who had been failed by the modern medical system.

Libbe Englander, PhD ( - Pharm3r CEO and former BioTech Fund Manager - Libbe founded Pharm3r, a healthcare analytics company, in 2011. Pharm3r improves client outcomes by processing vast quantities of real world data to create predictive models of drug and device risk. Prior to Pharm3r she founded, ran and successfully sold a healthcare hedge fund. Libbe has a Ph.D. in Molecular Biology from The Rockefeller University and a B.S. in Biology from Yale University.

Christopher Morris, MD ( - Hospitalist and Associate Director for Digital Health Innovation at NYU Langone Health - Internist and digital health champion focused on creating strategic development partnerships with health tech start-ups as a means to transform healthcare through improved clinical and quality outcomes. I am particularly interested in emerging telehealth technologies that re-invent the primary care experience.

Joe Korff ( - Principal & Founder, The ARC Companies - Real Estate and Healthcare Investor -The Arc Companies focuses on value add real estate development and startups. In the startup space, portfolio investments have been made in diverse areas from digital health, medical devices, pharma, industrial internet, gaming, cyber, fin tech, search and data science platforms, among other areas.

Moderator: Sherman Williams II (, Director – Investment Banking, Chardan Capital Markets - Sherman Williams is a former Naval Officer and is currently an Investment Banker focused on MedicalTechnology, specifically Life Sciences, Tools, Diagnostics and Medical Devices at Chardan. During his tenure as an Investment Banker, Sherman has executed numerous M&A, Equity and Debt Capital Raise transactions at William Blair & Co. in Chicago and Greenhill & Co and Chardan in New York City. Sherman is a graduate of the U.S. Naval Academy and the University of Chicago Booth School of Business where he focused on Finance, Accounting,International Business and Entrepreneurship.

Startups Pitching

Harmonigenic ( - Metastasis prediction via a novel photonics technique

Mirrorme3D ( - 3d models to improve the plastic surgery experience

Haystack - Predictive profiling for early cancer detection using proteomics

Valisure ( - a novel digital pharmacy that dispenses chemically-validated medications to ensure quality and consistency

Gencove ( - Low-coverage whole genome sequencing